Arihant Capital Markets Ltd
Incorporated in 1992, Arihant Capital
Markets Ltd provides Stock & Commodities Broking, PMS, Financial Services, Real Estate, Insurance Broking and other related activities[1]
- Market Cap ₹ 781 Cr.
- Current Price ₹ 74.6
- High / Low ₹ 120 / 56.3
- Stock P/E 21.0
- Book Value ₹ 36.2
- Dividend Yield 0.67 %
- ROCE 21.6 %
- ROE 15.6 %
- Face Value ₹ 1.00
Pros
- Debtor days have improved from 259 to 146 days.
Cons
- Promoter holding has decreased over last quarter: -2.14%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Capital Markets Stockbroking & Allied
Part of BSE Allcap BSE Financial Services
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | 49 | 45 | 77 | 94 | 80 | 79 | 109 | 152 | 132 | 229 | 241 | 199 | |
| 27 | 35 | 33 | 42 | 52 | 47 | 47 | 60 | 86 | 85 | 126 | 151 | 128 | |
| Operating Profit | 8 | 14 | 13 | 35 | 42 | 32 | 32 | 49 | 67 | 48 | 103 | 91 | 71 |
| OPM % | 23% | 28% | 28% | 45% | 45% | 40% | 41% | 45% | 44% | 36% | 45% | 38% | 36% |
| -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 1 | 4 | 1 | |
| Interest | 1 | 3 | 3 | 12 | 13 | 9 | 8 | 4 | 7 | 11 | 14 | 21 | 20 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 3 | 10 | 9 | 22 | 29 | 22 | 23 | 44 | 68 | 36 | 87 | 71 | 49 |
| Tax % | 25% | 30% | 34% | 34% | 30% | 30% | 24% | 21% | 20% | 26% | 24% | 25% | |
| 3 | 7 | 6 | 15 | 20 | 16 | 18 | 35 | 54 | 26 | 66 | 53 | 37 | |
| EPS in Rs | 0.24 | 0.68 | 0.58 | 1.43 | 1.92 | 1.49 | 1.71 | 3.34 | 5.19 | 2.52 | 6.32 | 5.09 | 3.56 |
| Dividend Payout % | 62% | 11% | 26% | 10% | 8% | 10% | 12% | 6% | 6% | 16% | 8% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 25% |
| 3 Years: | 17% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 35% |
| 3 Years: | 18% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 20% |
| 3 Years: | 18% |
| Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 42 | 46 | 51 | 65 | 84 | 98 | 114 | 147 | 197 | 222 | 283 | 339 | 368 |
| 0 | 0 | 0 | 8 | 91 | 98 | 35 | 48 | 78 | 51 | 92 | 82 | 189 | |
| 31 | 31 | 33 | 55 | 61 | 70 | 138 | 217 | 267 | 205 | 365 | 306 | 339 | |
| Total Liabilities | 83 | 88 | 93 | 140 | 247 | 276 | 297 | 422 | 553 | 488 | 751 | 737 | 907 |
| 10 | 8 | 8 | 8 | 10 | 10 | 9 | 9 | 10 | 14 | 15 | 28 | 30 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 18 | 25 | 12 | 29 | 16 | 29 | 21 | 23 | 29 | 23 | 16 | 20 | 31 |
| 56 | 54 | 73 | 103 | 220 | 238 | 266 | 390 | 514 | 452 | 721 | 689 | 847 | |
| Total Assets | 83 | 88 | 93 | 140 | 247 | 276 | 297 | 422 | 553 | 488 | 751 | 737 | 907 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 4 | -8 | 4 | -38 | 8 | 117 | -31 | -21 | 16 | -36 | 27 | |
| 0 | -8 | 12 | -17 | 11 | -4 | -2 | -4 | 9 | 0 | 9 | -12 | |
| -2 | -2 | -4 | 8 | 81 | -4 | -72 | 9 | 22 | -36 | 30 | -21 | |
| Net Cash Flow | 7 | -6 | 1 | -4 | 54 | 0 | 43 | -26 | 10 | -20 | 3 | -6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 99 | 142 | 203 | 295 | 449 | 587 | 297 | 482 | 470 | 476 | 154 | 146 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 99 | 142 | 203 | 295 | 449 | 587 | 297 | 482 | 470 | 476 | 154 | 146 |
| Working Capital Days | -76 | -23 | 108 | 81 | -30 | 339 | -359 | -168 | -79 | -48 | -341 | -209 |
| ROCE % | 15% | 24% | 20% | 47% | 31% | 16% | 17% | 27% | 27% | 16% | 30% | 22% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10 Feb - On publication of newspaper advertisement pertaining to Unaudited Financial Results for the quarter and nine months ended on December 31, 2025
-
Announcement under Regulation 30 (LODR)-Change in Management
9 Feb - Arpit Jain re-appointed Joint MD w.e.f. 25 Jan 2026 for 4y5m; Jitendra Jain re-appointed Independent Director for 5 years.
-
Statement Of Deviation Or Variation In The Use Of Proceeds Of The Conversion Of Warrants Into Equity Shares On Preferential Basis For The Quarter And Nine Months Ended December 31, 2025.
9 Feb - No deviation; ₹34.25 crore via warrant conversion on 22-Nov-2025 fully utilized.
-
Submission Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025 Along With The Limited Review Report Issued By Statutory Auditor Of The Company
9 Feb - Approved unaudited Q3/9M results (ended Dec 31, 2025); re-appointed Arpit Jain (JMD) and Jitendra Jain.
-
Board Meeting Outcome for Outcome Of Board Meeting
9 Feb - Unaudited Q3/9M FY26 results; Q3 net profit ₹517.80L, 9M ₹3,096.39L; reappointed JMD and independent director.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
ACML acts as a stock and commodities broker to execute proprietary trades on behalf of its clients which include retail customers (including high net worth individuals), mutual funds, financial institutions and corporate clients.